Cargando…
Conventional and Kampo Medicine Treatment for Mild-to-moderate COVID-19: A Multicenter, Retrospective, Observational Study by the Integrative Management in Japan for Epidemic Disease (IMJEDI Study-observation)
OBJECTIVE: Patients in whom coronavirus disease 2019 (COVID-19) was suspected or confirmed between January 1, 2020, and October 31, 2021, were enrolled from Japanese hospitals in this multicenter, retrospective, observational study. METHODS: Data on the treatment administered (including conventional...
Ejemplares similares
-
A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial
por: Takayama, Shin, et al.
Publicado: (2020) -
A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study)
por: Namiki, Takao, et al.
Publicado: (2021) -
Editorial: Potentials of Kampo Medicine in Modern Society
por: Nakae, Hajime, et al.
Publicado: (2022) -
Case Report: Kampo Medicine for Non-tuberculous Mycobacterium Pulmonary Disease
por: Suzuki, Tomoko, et al.
Publicado: (2021) -
Japanese traditional Kampo medicine bofutsushosan improves body mass index in participants with obesity: A systematic review and meta-analysis
por: Uneda, Kazushi, et al.
Publicado: (2022)